FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 251 filers reported holding FATE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,237,000 | -97.2% | 31,900 | -95.8% | 0.01% | -97.3% |
Q4 2021 | $44,317,000 | -67.7% | 757,425 | -67.2% | 0.22% | -65.4% |
Q3 2021 | $136,997,000 | -17.1% | 2,311,398 | +21.3% | 0.64% | -5.3% |
Q2 2021 | $165,335,000 | +5.5% | 1,905,000 | +0.3% | 0.68% | -13.2% |
Q1 2021 | $156,655,000 | -42.6% | 1,900,000 | -36.7% | 0.78% | -52.6% |
Q4 2020 | $272,790,000 | +118.4% | 3,000,000 | -4.0% | 1.64% | +89.9% |
Q3 2020 | $124,906,000 | +4.0% | 3,125,000 | -10.7% | 0.86% | -10.1% |
Q2 2020 | $120,085,000 | +80.2% | 3,500,000 | +16.7% | 0.96% | +68.0% |
Q1 2020 | $66,630,000 | +51.3% | 3,000,000 | +33.3% | 0.57% | +92.6% |
Q4 2019 | $44,033,000 | +26.0% | 2,250,000 | 0.0% | 0.30% | +12.5% |
Q3 2019 | $34,943,000 | -31.1% | 2,250,000 | -10.0% | 0.26% | -20.0% |
Q2 2019 | $50,750,000 | +15.5% | 2,500,000 | 0.0% | 0.33% | 0.0% |
Q1 2019 | $43,925,000 | +55.6% | 2,500,000 | +13.6% | 0.33% | +59.4% |
Q4 2018 | $28,226,000 | +226.9% | 2,200,000 | +315.1% | 0.21% | +305.9% |
Q3 2018 | $8,634,000 | +881.1% | 530,000 | +209.6% | 0.05% | +264.3% |
Q3 2014 | $880,000 | -43.8% | 171,196 | -31.0% | 0.01% | -39.1% |
Q2 2014 | $1,566,000 | -41.5% | 248,102 | -9.8% | 0.02% | -56.6% |
Q1 2014 | $2,679,000 | -21.6% | 275,000 | -49.5% | 0.05% | -25.4% |
Q4 2013 | $3,418,000 | – | 544,243 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
XTX Topco Ltd | 192,920 | $408,990 | 0.07% |